SCR-LIP-000781 · Claim · machine-readable JSON →
Findings are inconsistent on whether quality-of-life and psychological burden worsen with more advanced lipedema stage.
General proposition consolidated from 3 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 3 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (3)
- Stages of lipoedema: experiences of physical and mental health and health care — Clarke et al. (2023) ✓ verified — consistent · cross sectional · 2023 · reading confidence: high
Stage 3-4 vs 1-2: depression 48.3% vs 34.8% (p<0.001), staying home 64.3% vs 44.4%, life dissatisfaction 35.7% vs 22.0%; inferiority feelings high across stages.
Large cross-sectional survey directly reports depression, anxiety-related symptoms (fearfulness), social isolation, and life dissatisfaction in lipedema patients, with worse outcomes at advanced stages; findings are self-reported and unadju - Characteristics and Patient Reported Outcome Measures in Lipedema Patients—Establishing a Baseline for Treatment Evaluation in a High-Volume Center — Hamatschek et al. (2022) ✓ verified — consistent · cross sectional · 2022 · reading confidence: high
In 511 patients, QoL impairment correlated with stage (r=0.55, p<0.001) and PHQ-9 with stage (r=0.2, p=0.002); PHQ-9 mean 10.84, 54% at risk of moderate-to-severe depression.
Large cross-sectional study using validated PROMs (WHOQOL-BREF, PHQ-9) directly quantifying quality of life and depression in lipedema patients, with stage-dependent correlations; directly addresses the question's affirmative direction. - Clinical characteristics, comorbidities, and correlation with advanced lipedema stages: A retrospective study from a Swiss referral centre — Luta et al. (2025) ✓ verified — refining · cross sectional · 2025 · reading confidence: high
In 239 patients, anxiety 64.4%, depression 23.4%, low PCS-SF36 71.5% and MCS-SF36 67.4%, with none of these differing significantly across disease stages (p>0.5).
Retrospective referral-centre study with validated instruments (SF-36, HADS, BPI, FSS) directly quantifying quality of life, depression, and anxiety in lipedema patients, showing high psychosocial burden dissociated from disease stage.
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000041